)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Cytokinetics (CYTK) investor relations material
Cytokinetics Jefferies London Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Jefferies London Healthcare Conference 2025 summary17 Nov, 2025
Strategic vision and pipeline progress
Focused on muscle biology, with aficamten as lead myosin modulator pending regulatory review for OHCM; PDUFA date set for December 26 and potential China approval in Q4.
EMA approval targeted for early next year, aiming for commercialization across three continents.
Franchise strategy centers on specialty cardiology, with additional myosin modulators in development and plans for launches in Japan via Bayer partnership.
SEQUOIA and MAPLE phase III studies show aficamten's significant efficacy and superiority over standard care in OHCM.
Strong financial position with over $1 billion expected by year-end, supporting business ambitions and future launches.
Product differentiation and market strategy
Aficamten offers differentiated pharmacology: flexible dosing, rapid titration, shallow exposure-response, and reduced drug-drug interactions.
Differentiated REMS and patient services expected to drive preference and wider adoption post-launch.
MAPLE data demonstrates beta blockers are ineffective in OHCM, supporting a shift to CMIs.
Launch metrics will focus on number of prescribing physicians and patients on therapy, with initial access via free drug and gradual conversion to paid scripts.
Commercial access expected to reach 70-75% of lives by late next year, with Medicare coverage limited and medical exception processes required.
Market expansion and adoption dynamics
Market growth expected through increased prescriber base and community unlock, with MAPLE and REMS differentiation as catalysts.
MAPLE data anticipated to influence guidelines by 2027, accelerating adoption among early and later adopters.
Guidelines in the US and EU likely to be molecule-specific, with aficamten potentially elevated in treatment algorithms.
Patient adds for the CMI class could increase with aficamten's entry, depending on timing of guideline updates and prescriber behavior.
Strategic urgency in the sector is rising, with increased competition and premiums for valuable assets.
How will AFI expand the CMI market beyond current trends?
Acacia: What underpins confidence in trial design
Maple data: How will it influence CMI class adoption
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Cytokinetics earnings date
Q4 202527 Feb, 2026
Next Cytokinetics earnings date
Q4 202527 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cytokinetics Inc is a biopharmaceutical company focused on developing small-molecule therapies aimed at muscle function. The company targets diseases associated with impaired cardiac and skeletal muscle performance, including heart failure and neuromuscular disorders. Its operations include clinical development and research. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage